# Pharmacokinetics, Safety, and Efficacy of SPRIX in 12 to 17 Year Old Patients vs. Adult Patients Undergoing Open Surgical Procedures

> **NCT01819610** · PHASE3 · COMPLETED · sponsor: **American Regent, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** SPRIX

## Key facts

- **NCT ID:** NCT01819610
- **Lead sponsor:** American Regent, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-03
- **Final completion:** 2014-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01819610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01819610, "Pharmacokinetics, Safety, and Efficacy of SPRIX in 12 to 17 Year Old Patients vs. Adult Patients Undergoing Open Surgical Procedures". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01819610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*